Position in IMVT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$52,299,966
+$12,620,973 QoQ
Shares Held
1,357,383
-15.0% QoQ
Ownership
0.657%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#22
of 226 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Derivatives in IMVT
reported options exposure · as of Jun 30, 2024CallValue
$5,280,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $5,490,398,452 across 69 Biotechnology names. IMVT ranks #24 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $681,627,752 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
4,319,496 | $383,484,854 | |
| 3 | CELC |
Celcuity Inc.
|
3,197,200 | $334,491,064 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,163,721 | $310,387,665 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,586,295 | $287,156,333 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
8,085,461 | $286,144,464 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
14,106,187 | $263,926,758 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
3,752,574 | $213,183,728 |
All Filings in IMVT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,299,966 | 1,357,383 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $39,678,993 | 1,597,383 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $50,710,103 | 1,994,890 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,596,786 | 1,587,890 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $34,206,240 | 2,137,890 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $48,605,190 | 2,844,072 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $52,987,959 | 2,139,199 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $67,818,504 | 2,378,762 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $50,787,950 | 1,923,786 | Shares | Sole | 2024-08-16 | |
| 2024-06-30 | $5,280,000 | 200,000 | Call | Sole | 2024-08-16 | |
| 2024-03-31 | $95,741,379 | 2,963,212 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $3,231,000 | 100,000 | Call | Sole | 2024-08-06 | |
| 2023-12-31 | $98,082,094 | 2,328,082 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $146,445,987 | 3,814,691 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $47,876,163 | 2,523,783 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $20,036,717 | 1,291,858 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,662,500 | 150,000 | Shares | Sole | 2023-02-14 | |
| 2020-12-31 | $64,666,000 | 1,400,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $49,266,000 | 1,400,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $26,785,000 | 1,100,000 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||